DCGI
Latest news and video coverage curated from trusted media outlets
| 0 shares | ShareTweetSavePostSend |
You Might Like
Akums Reports Q4 FY25 with 12.4% Revenue Growth, FY25 Adj. EBITDA Remained Strong at 12.3%*Akums Drugs and Pharmaceuticals Ltd.*, India's largest contract development and manufacturing organization (CDMO), has announced its consolidated financial results for the quarter and fiscal year..NewsVoir - Published | |
Aurigene Oncology gets DCGI nod for phase-2 trials of CAR-T cell therapy Ribrecabtagene autoleucelDr Reddy’s Laboratories' subsidiary, Aurigene Oncology Limited, received DCGI approval to conduct a phase-2 trial for India's first novel autologous BCMA directed CAR-T cell therapy, Ribrecabtagene..IndiaTimes - Published | |
DCGI suspends ENTOD's PresVu eye drops licence after misleading marketing claims, company to challenge order in courtThe drug regulator said the company made claims for the drug product for which it had not obtained approval from the Central Licensing Authority, thereby violating provisions under the New Drugs and..DNA - Published | |
DCGI approves vision-correcting eye dropsEntod Pharmaceuticals has unveiled PresVu, India's first eye drop developed to lessen dependence on reading glasses for those with presbyopia. Affecting people over 40, this condition hampers the..IndiaTimes - Published | |
India to withdraw AstraZeneca's cancer drugDCGI orders withdrawal of AstraZeneca's Olaparib tablets for gBRCA mutation and advanced ovarian cancer due to potential adverse effects. The drug was approved in 2018 for adult patients with ovarian..IndiaTimes - Published | |
DCGI bans all charges, except supply, processing costs on blood unitsThe Drugs Controller General of India (DCI) on Thursday banned all charges except supply and processing costs on blood units.DNA - Published | |
Blood not for sale, charge processing cost only, DCGI tells blood banksDCGI has also asked the drug controller cum licensing authorities to direct all blood centres to adhere to the revised guidelines for recovery of processing charges. When a person donates blood, it is..IndiaTimes - Published | |
MAHE Celebrates Graduates in Grand Convocation Finale*Manipal Academy of Higher Education's (MAHE)* 31^st Convocation concluded on 26^th November. It marked the end of an emotional and joyous four days during which distinguished leaders and guests joined..NewsVoir - Published | |
Breaking Ground in Academia: MAHE Honors Innovators and Researchers at Grand Convocation*Manipal Academy of Higher Education (MAHE)*, an Institution of Eminence, deemed to be University, one of Indias leading research focused educational institutions, held a convocation to discuss various..NewsVoir - Published | |
Rule regulating Ayush ads set to go, but amendments to fill void in limbo for a yearThe Drug Controller General of India (DCGI) has suggested that a rule regulating the advertisement of ayush drugs should only be withdrawn after amendments to the Drugs and Magic Remedies Act are..IndiaTimes - Published | |
DCGI: In case of adverse reaction, don't use Digene gelThe Drug Controller General of India (DCGI) has advised doctors and healthcare professionals to educate their patients to discontinue the use of Digene gel - a commonly prescribed anti-acidity..IndiaTimes - Published | |
DCGI issues advisory against Digene GelnewKerala.com - Published | |
Antacid Digene Gel recalled by Abbott, DCGI issues alert against household medication; know whyDigene Gel, which is used as an antacid in many Indian homes, is now under the radar of the DGCI as an alert has been issued after the product's recall.DNA - Published | Warning on common cough syrups; know moreDrugs Controller General of India (DCGI) has warned against the use of pholcodine-containing cold and cough drugs. The warning from the country's drug regulatory authority comes after the World..IndiaTimes - Published |
After WHO, DCGI issues alert against use of pholcodine-containing cough syrupsWHO warns of anaphylactic risks for those who took pholcodine cough syrups before anesthesia with NMBAs.DNA - Published | Intas launches DCGI-approved Tofacitinib Topical (JAKi) in Auto-Immune Condition Atopic Dermatitis (AD) for Indian patientsnewKerala.com - Published |
India's 1st mRNA Omicron booster vax gets DCGI nod, to launch in 2-3 weeksnewKerala.com - Published | Mandatory testing of cough syrup before exports, DCGI asks labs to give top priority to such samplesCough syrup exporters will have to produce a certificate of analysis issued by a government laboratory before the product is exported, effective June 1, the Directorate General of Foreign Trade (DGFT)..IndiaTimes - Published |
Covid jab Covovax as heterologous booster to be available on CoWIN soon; to cost Rs 225 per doseCovovax can be administered to those who have already vaccinated with Covishield or Covaxin. The Drugs Controller General of India (DCGI) on January 16 had approved the market authorisation for Covovax..IndiaTimes - Published | Cabinet clears Rajeev Singh Raghuvanshi's name as new DCGInewKerala.com - Published |
Dr PBN Prasad to hold charge as DCGI on temporary basisnewKerala.com - Published | DCGI approves Keytruda for treatment of cervical cancer: MSDnewKerala.com - Published |
Govt to introduce incentive scheme to boost R&D by pharma industry: DCGI SomaniPLI scheme aims to give companies incentives on incremental sales from products manufactured in domestic units.Mid-Day - Published | Serum Institute seeks inclusion of Covid jab Covovax in CoWIN portal as heterologous booster dose for adultsCovid-19 vaccine India: The Drug Controller General of India (DCGI) on January 16 approved market authorisation for Covovax as a heterologous booster dose for adults who have been administered two..Zee News - Published |
Covid vaccine news: SII's Covovax approved as heterologous booster dose for adultsDCGI has approved market authorisation to COVID-19 vaccine Covovax as a heterologous booster dose for adults.DNA - Published | DCGI recommends Covovax as heterologous booster dosenewKerala.com - Published |
